Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3681791

CCC[N+](C)(C)C.O=C([O-])C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 3/20 0.38
ADRA2A P08913 1/20 0.37
ADRA1A P35348 1/20 0.37
FAAH O00519 8/20 0.35
MAPT P10636 1/20 0.35
BLM P54132 1/20 0.35
CES1 P23141 5/20 0.34
CES2 O00748 3/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ACHE P22303 1/20 0.33
FFAR3 O14843 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
GALR3 O60755 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL31514394 0.98 BLM (0.39) BBOX1ADRA2AADRA1AFAAHMAPT
Trifluoroacetic Acid SCHEMBL1981477 0.87 DNM1 (0.44) BBOX1FAAHCES1CES2MEN1
Pivalate SCHEMBL4928408 0.84 BBOX1 (0.39) BBOX1ADRA2AADRA1AMAPTBLM
Tetrapropylammonium SCHEMBL107306 0.84 SLC22A1 (0.48) FAAHCES1CES2MEN1CYP1A2
Cetrimonium SCHEMBL4809388 0.84 DNM1 (0.58) FAAHCES1CES2MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL15355428 0.84 DNM1 (0.58) FAAHCES1CES2MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL15355521 0.83 BBOX1 (0.41) BBOX1FAAHCES1CES2MEN1
Bicarbonate SCHEMBL1896982 0.83 BBOX1 (0.43) BBOX1ADRA2AADRA1ACES1CES2
Trifluoroacetic Acid SCHEMBL29795709 0.83 BBOX1 (0.53) BBOX1FAAHCES1CES2MEN1
Choline SCHEMBL3784402 0.82 LMNA (0.52) BBOX1ADRA2AADRA1AMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115667933-A Reagent for mass spectrometry 豪夫迈·罗氏有限公司 2023-01-31 CN disclosed
US-8410150-B2 Inhibitors of carnitine palmitoyltransferase and treating cancer UNIVERSITY HEALTH NETWORK (CA) 2013-04-02 US disclosed
US-20100105900-A1 INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER UNIVERSITY HEALTH NETWORK 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105900-A1 INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER CPT1A, CPT1B, CPT2 BBOX1 1417/4885ADRA2A 2720/4885ADRA1A 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.